Wed. Sep 18th, 2024

The Houstonian Review

Reviewing Only The Best of Houston

After closing crowdfunding round, Houston biotech co. FibroBiologics reconsiders IPO route

1 min read

FibroBiologics co-founder and CEO Pete O’Heeron told the Houston Business Journal the funding would help the company progress towards its eventual listing as a public company.

Leave a Reply

Your email address will not be published.

Generated by Feedzy